Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting

Trial Profile

Pharmacodynamic comparison of different oral P2Y12-receptor inhibitor loading strategies for transitioning from cangrelor in patients undergoing coronary stenting

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Feb 2018

At a glance

  • Drugs Cangrelor (Primary) ; Clopidogrel; Prasugrel; Ticagrelor
  • Indications Coronary disorders
  • Focus Therapeutic Use
  • Acronyms ExcelsiorLOAD2
  • Most Recent Events

    • 01 Feb 2018 Results assessing the impact of Reticulated Platelets on the Antiplatelet Effect of Cangrelor, published in the Thrombosis and Haemostasis
    • 01 Sep 2017 Results published in the ESC Congress 2017: Annual Congress of the European Society of Cardiology
    • 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top